Medicare Enrolled
Dr. Artin Minaeian, M.D.
Neurology · Glendale, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Minaeian from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Minaeian?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Minaeian
Dr. Artin Minaeian is a neurology specialist in Glendale, CA, with 12 years of NPI registration. Based on federal Medicare data, Dr. Minaeian performed 4,053 Medicare services across 3,104 unique beneficiaries.
Between the years covered by Open Payments, Dr. Minaeian received a total of $117,923 from 91 pharmaceutical and/or device companies across 1354 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Minaeian is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 12 years in practice
▲ Top 16% volume in CA
$117,923 industry payments
Medicare Practice Summary
Medicare Utilization ↗4,053
Medicare services
Top 16% in CA for neurology
3,104
Unique beneficiaries
$137
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~338 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
570 | $88 | $242 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
490 | $94 | $227 |
| Neurobehavioral status exam, first hour A clinical assessment of neurobehavioral status lasting one hour. This evaluation examines mental and behavioral functions. |
446 | $68 | $214 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
445 | $134 | $325 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
313 | $138 | $440 |
| New patient office visit, complex (60-74 min) | 234 | $153 | $458 |
| Complete ultrasound of brain blood flow An ultrasound test that evaluates blood flow within the brain's blood vessels. It uses sound waves to create images of the vessels and assess circulation. |
200 | $188 | $643 |
| Ultrasound of brain blood flow following medication An ultrasound test used to assess blood flow within the brain after a medication has been administered. |
199 | $191 | $652 |
| Ultrasound of brain blood flow An ultrasound test used to examine blood flow within the brain to check for blood clots. |
199 | $141 | $734 |
| Ultrasound of head and neck blood flow, bilateral An ultrasound exam that uses sound waves to visualize and assess blood flow in the vessels of both the head and the neck. |
198 | $123 | $469 |
| EEG, extended monitoring A test that records electrical activity in the brain while the patient is both awake and asleep. |
188 | $384 | $1,020 |
| Digital analysis of brain wave activity (EEG) This procedure involves the digital analysis of brain wave activity recorded via an electroencephalogram (EEG). It focuses on the technical interpretation of the digital data rather than the initial recording or supervision. |
187 | $238 | $593 |
| Critical care, first 30-74 min Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient. |
129 | $168 | $615 |
| Bilateral facial and neck nerve muscle paralysis injection Injection of a chemical agent to paralyze muscles in the face and neck on both sides. |
80 | $110 | $331 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
76 | $109 | $363 |
| Neuropsychological test evaluation, first hour A professional assessment of cognitive and behavioral functioning using standardized tests. This service covers the initial hour of the evaluation process. |
42 | $102 | $294 |
| Psychological test administration, first 30 minutes A technician administers psychological or neuropsychological testing for the first 30 minutes. |
42 | $27 | $90 |
| Nursing facility visit, moderate complexity A follow-up visit by a healthcare provider at a nursing facility for an established patient. The visit involves moderate medical decision making and takes at least 30 minutes. |
15 | $72 | $201 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$117,923
Total received (2018-2024)
Avg $16,846/year across 7 years
Top 6% in CA for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
91
Companies
1,354
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$67,041 (56.9%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$27,203 (23.1%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$23,678 (20.1%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$44,266
2023
$14,649
2022
$18,111
2021
$19,706
2020
$7,455
2019
$10,920
2018
$2,817
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Lilly USA, LLC
$16,383
Eisai Inc.
$14,945
ABBVIE INC.
$6,901
TG Therapeutics, Inc.
$1,382
EMD Serono, Inc.
$458
Celgene Corporation
$357
Lundbeck LLC
$293
ARGENX US, INC.
$284
UCB, Inc.
$280
Neurelis, Inc.
$258
Alexion Pharmaceuticals, Inc.
$228
Amneal Pharmaceuticals LLC
$211
SK Life Science, Inc.
$203
PFIZER INC.
$194
Otsuka America Pharmaceutical, Inc.
$181
Novartis Pharmaceuticals Corporation
$175
Mallinckrodt Hospital Products Inc.
$171
Neurocrine Biosciences, Inc.
$156
Genentech USA, Inc.
$155
MDD US Operations, LLC
$154
AstraZeneca Pharmaceuticals LP
$136
Biogen, Inc.
$121
ACADIA Pharmaceuticals Inc
$115
Imperative Care, Inc
$94
ANI Pharmaceuticals, Inc.
$70
Amgen Inc.
$64
Sumitomo Pharma America, Inc.
$46
Teva Pharmaceuticals USA, Inc.
$44
JAZZ PHARMACEUTICALS INC.
$33
Avid Radiopharmaceuticals, Inc.
$32
GENZYME CORPORATION
$30
LivaNova USA, Inc.
$27
Merz Pharmaceuticals, LLC
$25
Alnylam Pharmaceuticals Inc.
$23
GE HEALTHCARE
$19
Aucta Pharmaceuticals, Inc.
$18
Top 3 companies account for 86.4% of 2024 payments
All-time payments by company (2018-2024) ›
ABBVIE INC.
$20,718
Lilly USA, LLC
$16,694
Teva Pharmaceuticals USA, Inc.
$16,256
Eisai Inc.
$15,122
AbbVie Inc.
$14,800
EMD Serono, Inc.
$4,298
Biohaven Pharmaceutical Holding Company Ltd.
$4,058
Medtronic Vascular, Inc.
$2,164
Biogen, Inc.
$1,736
UCB, Inc.
$1,658
Allergan, Inc.
$1,385
TG Therapeutics, Inc.
$1,382
Novartis Pharmaceuticals Corporation
$1,096
Celgene Corporation
$1,034
Alexion Pharmaceuticals, Inc.
$913
Amgen Inc.
$847
SK Life Science, Inc.
$739
Lundbeck LLC
$707
ACADIA Pharmaceuticals Inc
$670
Janssen Pharmaceuticals, Inc
$653
Amneal Pharmaceuticals LLC
$537
Medtronic, Inc.
$511
Allergan Inc.
$499
AstraZeneca Pharmaceuticals LP
$462
Supernus Pharmaceuticals, Inc.
$452
LivaNova USA, Inc.
$423
PFIZER INC.
$418
Neurocrine Biosciences, Inc.
$410
MDD US Operations, LLC
$403
Horizon Therapeutics plc
$378
Acorda Therapeutics, Inc
$374
ARGENX US, INC.
$370
GENZYME CORPORATION
$346
Neurelis, Inc.
$322
Genentech USA, Inc.
$316
Imperative Care, Inc
$310
Boston Scientific Corporation
$267
Avanir Pharmaceuticals, Inc.
$261
Otsuka America Pharmaceutical, Inc.
$250
Sunovion Pharmaceuticals Inc.
$233
Adamas Pharmaceuticals, Inc.
$226
Alnylam Pharmaceuticals Inc.
$185
Mallinckrodt Hospital Products Inc.
$171
Abbott Laboratories
$167
Stryker Corporation
$165
Medtronic USA, Inc.
$164
Corium, LLC
$163
TG THERAPEUTICS, INC.
$158
Kyowa Kirin, Inc.
$154
Viz.ai, Inc.
$125
Biohaven Pharmaceuticals, Inc.
$116
Janssen Scientific Affairs, LLC
$106
UPSHER-SMITH LABORATORIES LLC
$104
Takeda Pharmaceuticals U.S.A., Inc.
$89
Sumitomo Pharma America, Inc.
$82
ARBOR PHARMACEUTICALS, INC.
$75
Akcea Therapeutics, Inc.
$71
ANI Pharmaceuticals, Inc.
$70
Genentech, Inc.
$68
Octapharma USA, Inc.
$68
Catalyst Pharmaceuticals, Inc.
$57
Upsher-Smith Laboratories LLC
$57
Vertical Pharmaceuticals, LLC
$56
Galderma Laboratories, L.P.
$51
Arbor Pharmaceuticals, Inc.
$40
E.R. Squibb & Sons, L.L.C.
$38
Microtransponder, Inc.
$38
GE HEALTHCARE
$36
DePuy Synthes Sales Inc.
$33
JAZZ PHARMACEUTICALS INC.
$33
Avid Radiopharmaceuticals, Inc.
$32
Vertiflex, Inc.
$32
Merz North America, Inc.
$32
Bayer HealthCare Pharmaceuticals Inc.
$31
US WorldMeds, LLC
$31
Greenwich Biosciences, Inc.
$26
PORTOLA PHARMACEUTICALS, INC.
$26
Merz Pharmaceuticals, LLC
$25
Mitsubishi Tanabe Pharma America, Inc.
$25
MicroVention, Inc.
$25
Harmony Biosciences LLC
$23
Cala Health, Inc.
$22
Novo Nordisk Inc
$20
BOSTON SCIENTIFIC CORPORATION
$20
CSL Behring
$19
Aucta Pharmaceuticals, Inc.
$18
BANNER LIFE SCIENCES, LLC
$18
MITSUBISHI TANABE PHARMA AMERICA, INC.
$18
Amylyx Pharmaceuticals, Inc.
$15
IDORSIA PHARMACEUTICALS US INC
$14
Currax Pharmaceuticals LLC
$12
Top 3 companies account for 45.5% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ACTIVA · ADLARITY · ADUHELM · AFINITOR · AIMOVIG · AJOVY · AMPYRA · AMVUTTRA · AMYVID · ANDEXXA · APOKYN · APTIOM · AUBAGIO · AUSTEDO · Activase · Adlarity · Aimovig · Austedo XR · BAFIERTAM · BOTOX · BOTOX COSMETIC · BOTOX THERAPEUTIC · BRILINTA · BRIUMVI · Betaseron · Briviact · CALA KIQ · CONTRAVE · COPAXONE · CREXONT · Confirm Rx · DUOPA · ELIQUIS · EMBOTRAP II Revascularization Device · EMGALITY · Edarbi · Enspryng · Epidiolex · FRED · FYCOMPA · Fycompa · GAMMAGARD · GENERAL DBS · GENERAL PAIN MANAGEMENT · GOCOVRI · General - DBS · Gocovri · Hizentra · Horizant · INBRIJA · INFINITY · INGREZZA · Infinity DBS Pulse Generators · KESIMPTA · KISUNLA · KYNMOBI · LEMTRADA · LINQ II · Leqembi · MAVENCLAD · MAYZENT · Mavenclad · Motpoly XR · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Nayzilam · Nourianz · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ONGENTYS · ONPATTRO · OSMOLEX ER · OXTELLAR XR · Ocrevus · Ocrevus Zunovo · Ongentys · PANZYGA · PURIFIED CORTROPHIN GEL · Ponvory · QULIPTA · QUVIVIQ · RADICAVA · RELYVRIO · REXULTI · RYTARY · Rebif · Repatha · Reveal LINQ · Rystiggo · SOLIRIS · SPINRAZA · SYNCHRO SELECT · Soliris · Solitaire · Superion ISS · TARGET · TECFIDERA · TEGSEDI · TOSYMRA · TOSYMRA SUMATRIPTAN NASAL SPRAY · TREVO · TRINTELLIX · TROKENDI XR · TYSABRI · Tosymra Sumatriptan Nasal Spray · Tresiba · UBRELVY · ULTOMIRIS · UPLIZNA · VALTOCO · VIIBRYD · VNS - Sentiva · VNS THERAPY SENTIVA MODEL 1000 GENERATOR · VNS Therapy · VNS Therapy SenTiva Model 1000 Generator · VRAYLAR · VUMERITY · VYEPTI · VYVGART · VYVGART HYTRULO · Vimpat · Viz.AI LVO · WAINUA · WATCHMAN · Wakix · XADAGO · XARELTO · XCOPRI · XEOMIN · XYWAV · Xadago · Xeomin · ZEMBRACE SYMTOUCH · ZEPOSIA · ZOOM 88-T LARGE DISTAL PLATFORM
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (57%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in neurology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 6% for neurology in CA.
Geographic Context
Neurologists within 10 mi
535
Per 100K population
5.4
County median income
$87,760
Nearest hospital
GLENDALE ADVENTIST MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Minaeian is a clinical cardiology specialist, with above-average Medicare volume (top 16% in CA), with speaking/promotional industry engagement in the top 6% of CA peers.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Minaeian experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Minaeian performed 570 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Minaeian receive payments from pharmaceutical companies?
Yes. Dr. Minaeian received a total of $117,923 from 91 companies across 1,354 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Minaeian's costs compare to other neurologists in Glendale?
Dr. Minaeian's average Medicare payment per service is $137. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Minaeian) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Neurology
Common procedures, typical costs, and what industry payments mean in neurology.
Same specialty & city
Neurologists in Glendale
Browse neurologists in Glendale ranked by procedure volume and transparency data.
Highest volume
Top Neurologists in CA
Neurologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Neurologists in CA
Which CA neurologists receive the most from drug and device companies.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
By company
Lilly USA, LLC Payments to Doctors
See all physicians who received payments from Lilly USA, LLC.
By company
Teva Pharmaceuticals USA, Inc. Payments to Doctors
See all physicians who received payments from Teva Pharmaceuticals USA, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology